NO20035055D0 - Substituerte pyrazinoner, pyridiner og pyrimidiner som corticotropin leverende faktor ligander - Google Patents

Substituerte pyrazinoner, pyridiner og pyrimidiner som corticotropin leverende faktor ligander

Info

Publication number: NO20035055D0
Authority: NO; Norway
Prior art keywords: corticotropin; pyridines; pyrimidines; factor ligands; supply factor
Prior art date: 2001-05-14

Application number

NO20035055A

Other languages

English (en)

Norwegian (no)

Inventor

Argyrios Georgios Arvanitis

Paul Joseph Gilligan

Richard A Hartz

Original Assignee

Bristol Myers Squibb Pharma Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-14

Filing date

2003-11-13

Publication date

2003-11-13

2003-11-13 Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co

2003-11-13 Publication of NO20035055D0 publication Critical patent/NO20035055D0/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Immunology (AREA)
Hematology (AREA)
Cardiology (AREA)
Diabetes (AREA)
Virology (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Transplantation (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
AIDS & HIV (AREA)
Child & Adolescent Psychology (AREA)
Obesity (AREA)
Endocrinology (AREA)

NO20035055A 2001-05-14 2003-11-13 Substituerte pyrazinoner, pyridiner og pyrimidiner som corticotropin leverende faktor ligander NO20035055D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29070601P	2001-05-14	2001-05-14
PCT/US2002/015493 WO2002092090A1 (en)	2001-05-14	2002-05-14	Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands

Publications (1)

Publication Number	Publication Date
NO20035055D0 true NO20035055D0 (no)	2003-11-13

Family

ID=23117196

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20035055A NO20035055D0 (no)	2001-05-14	2003-11-13	Substituerte pyrazinoner, pyridiner og pyrimidiner som corticotropin leverende faktor ligander

Country Status (22)

Country	Link
US (2)	US7205306B2 (cs)
EP (1)	EP1392309B1 (cs)
JP (1)	JP2004533447A (cs)
KR (1)	KR20030094410A (cs)
CN (1)	CN1527710A (cs)
BG (1)	BG108425A (cs)
BR (1)	BR0209575A (cs)
CA (1)	CA2446980A1 (cs)
CZ (1)	CZ20033053A3 (cs)
DE (1)	DE60217669D1 (cs)
EE (1)	EE200300546A (cs)
HU (1)	HUP0304048A2 (cs)
IL (1)	IL158669A0 (cs)
IS (1)	IS7017A (cs)
MX (1)	MXPA03010324A (cs)
NO (1)	NO20035055D0 (cs)
PL (1)	PL366577A1 (cs)
RU (1)	RU2003135424A (cs)
SK (1)	SK13752003A3 (cs)
WO (1)	WO2002092090A1 (cs)
YU (1)	YU90503A (cs)
ZA (1)	ZA200308729B (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1626965A1 (en) *	2003-05-09	2006-02-22	Pharmacia & Upjohn Company LLC	Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
BRPI0416853A (pt) *	2003-11-24	2007-02-13	Hoffmann La Roche	pirazolila e imidazolila pirimidinas
JP2008501758A (ja)	2004-06-09	2008-01-24	グラクソ　グループ　リミテッド	ピロロピリジン誘導体
GB0420722D0 (en) *	2004-09-17	2004-10-20	Addex Pharmaceuticals Sa	Novel allosteric modulators
GT200500284A (es) *	2004-10-15	2006-03-27	Aventis Pharma Inc	Pirimidinas como antagonistas del receptor de prostaglandina d2
US20060161001A1 (en) *	2004-12-20	2006-07-20	Amgen Inc.	Substituted heterocyclic compounds and methods of use
GT200600005A (es) *	2005-01-12	2006-08-16		Un derivado de 2-(aminocarbonilo ciclico)-indolina y una composicion farmaceutica que lo contiene
TW200640881A (en) *	2005-02-15	2006-12-01	Du Pont	Fungicidal pyrazine derivatives
TWI417095B (zh) *	2006-03-15	2013-12-01	Janssen Pharmaceuticals Inc	１，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
EP2034993A2 (en) *	2006-06-21	2009-03-18	E.I. Du Pont De Nemours And Company	Pyrazinones as cellular proliferation inhibitors
NZ578096A (en) *	2007-01-10	2011-11-25	Albany Molecular Res Inc	5-pyridinone substituted indazoles
WO2008107398A2 (en) *	2007-03-02	2008-09-12	Basf Se	Pyrazine compounds
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en)	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
ES2382982T3 (es) *	2007-07-21	2012-06-15	Albany Molecular Research, Inc.	Indazoles sustituidos con 5-piridinona y composiciones farmacéuticas de los mismos
CA2696948C (en) *	2007-09-14	2013-04-30	Jose Maria Cid-Nunez	1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
KR20100080597A (ko)	2007-09-14	2010-07-09	오르토-맥닐-얀센 파마슈티칼스 인코포레이티드	１,３-이치환된-４-페닐-1ｈ-피리딘-2-온
KR20100065191A (ko)	2007-09-14	2010-06-15	오르토-맥닐-얀센 파마슈티칼스 인코포레이티드	１,３-이치환된 ４-(아릴-ｘ-페닐)-１ｈ-피리딘-２-온
EP2220083B1 (en)	2007-11-14	2017-07-19	Janssen Pharmaceuticals, Inc.	Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EA022345B1 (ru) *	2008-04-29	2015-12-30	Мерк Патент Гмбх	Производные арилпиразинона в качестве стимуляторов секреции инсулина, способы их получения и их применение для лечения диабета
WO2010014687A1 (en) *	2008-07-31	2010-02-04	Bristol-Myers Squibb Company	Substituted carbamate derivatives as modulators of corticotropin-releasing factor receptor activity
CA2735764C (en)	2008-09-02	2016-06-14	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
AU2009304293B2 (en)	2008-10-16	2012-04-26	Addex Pharma S.A.	Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
BRPI0921333A2 (pt)	2008-11-28	2015-12-29	Addex Pharmaceuticals Sa	derivados de indol e benzoxazina como moduladores de receptores de glutamato metabotrópicos
NZ596078A (en)	2009-05-12	2013-06-28	Janssen Pharmaceuticals Inc	1,2,4-TRIAZOLO [4,3-a] PYRIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
EA020671B1 (ru)	2009-05-12	2014-12-30	Янссен Фармасьютикалз, Инк.	ПРОИЗВОДНЫЕ 1,2,4-ТРИАЗОЛО[4,3-a]ПИРИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CA2815002C (en)	2010-11-08	2019-10-22	Janssen Pharmaceuticals, Inc.	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN103298810B (zh)	2010-11-08	2016-03-16	杨森制药公司	1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
EP2643320B1 (en)	2010-11-08	2015-03-04	Janssen Pharmaceuticals, Inc.	1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
CN102786512A (zh) *	2012-05-31	2012-11-21	中国人民解放军军事医学科学院毒物药物研究所	N-芳基不饱和稠环叔胺类化合物及其制备方法和抗肿瘤应用
WO2014078568A1 (en)	2012-11-14	2014-05-22	The Johns Hopkins University	Methods and compositions for treating schizophrenia
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
KR102414246B1 (ko)	2014-01-21	2022-06-27	얀센 파마슈티카 엔.브이.	대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
LT3431106T (lt)	2014-01-21	2021-02-10	Janssen Pharmaceutica Nv	Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas
CN119613318B (zh) *	2024-11-29	2026-04-14	滁州市庆云医药有限公司	一种西洛多辛中间体及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0008864A1 (en) *	1978-08-15	1980-03-19	FISONS plc	Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them
IE63502B1 (en) *	1989-04-21	1995-05-03	Zeneca Ltd	Aminopyrimidine derivatives useful for treating cardiovascular disorders
DE4029648A1 (de) *	1990-09-19	1992-03-26	Hoechst Ag	4-anilino-pyrimidine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als fungizide
US5395817A (en) *	1992-01-22	1995-03-07	Imperial Chemical Industries Plc	N-arylindoles and their use as herbicides
FR2694004B1 (fr) *	1992-07-21	1994-08-26	Adir	Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
ES2128544T3 (es)	1992-12-17	1999-05-16	Pfizer	Pirrolopirimidinas como antagonistas del crf.
JP3398152B2 (ja)	1993-10-12	2003-04-21	ブリストル‐マイヤーズ・スクイブ・ファーマ・カンパニー	１ｎ−アルキル−ｎ−アリールピリミジンアミンおよびその誘導体
EP0901476A4 (en)	1996-03-26	2001-08-16	Du Pont Pharm Co	PYRIDINES AND PYRIMIDINES FUSION ARYLOXY AND ARYLTHIO AND DERIVATIVES THEREOF
US6107300A (en)	1996-03-27	2000-08-22	Dupont Pharmaceuticals	Arylamino fused pyrimidines
TW440563B (en) *	1996-05-23	2001-06-16	Hoffmann La Roche	Aryl pyrimidine derivatives and a pharmaceutical composition thereof
AU3064397A (en)	1996-05-24	1997-12-09	Dow Chemical Company, The	Process for preparing aliphatic ester compounds and alkanols
HU229024B1 (en)	1996-07-24	2013-07-29	Bristol Myers Squibb Pharma Co	Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
DE69710594T2 (de)	1996-09-16	2002-08-29	Du Pont Pharmaceuticals Co., Wilmington	Eine resorbierbare röntgenopake markierung enthaltendes chirurgisches implantat und verfahren zum verriegeln desselben in einem körper
CA2296014A1 (en)	1997-07-03	1999-01-14	Frank W. Hobbs	Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists
JP2002507996A (ja)	1997-07-03	2002-03-12	デュポンファーマシューティカルズカンパニー	神経学的障害を治療するためのイミダゾピリミジン類およびイミダゾピリジン類
WO1999011643A1 (en)	1997-09-02	1999-03-11	Du Pont Pharmaceuticals Company	Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders
CA2326884A1 (en)	1998-04-03	1999-10-14	Dupont Pharmaceuticals Company	Thiazolo¬4,5-d\|pyrimidines and pyridines as corticotropin releasing factor (crf) antagonists
US6124463A (en)	1998-07-02	2000-09-26	Dupont Pharmaceuticals	Benzimidazoles as corticotropin release factor antagonists
AU5777299A (en)	1998-08-21	2000-03-14	Du Pont Pharmaceuticals Company	Isoxazolo(4,5-d)pyrimidines as CRF antagonists

2002
- 2002-05-14 US US10/145,440 patent/US7205306B2/en not_active Expired - Lifetime
- 2002-05-14 BR BR0209575-0A patent/BR0209575A/pt not_active IP Right Cessation
- 2002-05-14 WO PCT/US2002/015493 patent/WO2002092090A1/en not_active Ceased
- 2002-05-14 JP JP2002589007A patent/JP2004533447A/ja active Pending
- 2002-05-14 MX MXPA03010324A patent/MXPA03010324A/es unknown
- 2002-05-14 HU HU0304048A patent/HUP0304048A2/hu unknown
- 2002-05-14 EP EP02729225A patent/EP1392309B1/en not_active Expired - Lifetime
- 2002-05-14 PL PL02366577A patent/PL366577A1/xx unknown
- 2002-05-14 IL IL15866902A patent/IL158669A0/xx unknown
- 2002-05-14 DE DE60217669T patent/DE60217669D1/de not_active Expired - Lifetime
- 2002-05-14 CN CNA028140907A patent/CN1527710A/zh active Pending
- 2002-05-14 CA CA002446980A patent/CA2446980A1/en not_active Abandoned
- 2002-05-14 EE EEP200300546A patent/EE200300546A/xx unknown
- 2002-05-14 RU RU2003135424/04A patent/RU2003135424A/ru not_active Application Discontinuation
- 2002-05-14 CZ CZ20033053A patent/CZ20033053A3/cs unknown
- 2002-05-14 SK SK1375-2003A patent/SK13752003A3/sk unknown
- 2002-05-14 YU YU90503A patent/YU90503A/sh unknown
- 2002-05-14 KR KR10-2003-7014755A patent/KR20030094410A/ko not_active Withdrawn
2003
- 2003-11-07 IS IS7017A patent/IS7017A/is unknown
- 2003-11-10 ZA ZA200308729A patent/ZA200308729B/en unknown
- 2003-11-13 NO NO20035055A patent/NO20035055D0/no not_active Application Discontinuation
- 2003-12-08 BG BG108425A patent/BG108425A/xx unknown
2007
- 2007-02-14 US US11/675,012 patent/US7319100B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
IL158669A0 (en)	2004-05-12
YU90503A (sh)	2006-03-03
BR0209575A (pt)	2004-04-20
EP1392309B1 (en)	2007-01-17
RU2003135424A (ru)	2005-05-20
PL366577A1 (en)	2005-02-07
BG108425A (en)	2004-12-30
EP1392309A1 (en)	2004-03-03
IS7017A (is)	2003-11-07
HK1059220A1 (en)	2004-06-25
EP1392309A4 (en)	2006-01-18
HUP0304048A2 (hu)	2004-04-28
DE60217669D1 (de)	2007-03-08
SK13752003A3 (en)	2004-11-03
WO2002092090A1 (en)	2002-11-21
CN1527710A (zh)	2004-09-08
KR20030094410A (ko)	2003-12-11
US20030171380A1 (en)	2003-09-11
US7319100B2 (en)	2008-01-15
CZ20033053A3 (en)	2004-05-12
MXPA03010324A (es)	2004-02-17
US7205306B2 (en)	2007-04-17
CA2446980A1 (en)	2002-11-21
US20070155740A1 (en)	2007-07-05
EE200300546A (et)	2004-04-15
ZA200308729B (en)	2005-02-10
JP2004533447A (ja)	2004-11-04

Legal Events

Date	Code	Title	Description
2006-02-06	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
IL158669A0 (en)	2004-05-12	Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
NO20052555L (no)	2005-07-07	5-substituerte pyrazin- eller pyridin-glucokinase-aktivatorer.
IS6518A (is)	2002-08-21	Pyridín, pyrimidín, pyrazín og tríazín setin með arýl og notkun þeirra
DE60333166D1 (de)	2010-08-12	Pyridin- und pyrimidin-derivate
PL370480A1 (en)	2005-05-30	Aminopyrimidines and pyridines
IS7520A (is)	2004-11-03	Pyrimidínonefnasambönd, samsetningar og aðferðir
HUS1500055I1 (hu)	2016-03-29	HIV-gátló pirimidinszármazékok
PL375390A1 (en)	2005-11-28	4-trifluoromethylpyrazolyl substituted pyridines and pyrimidines
MX267068B (es)	2009-05-29	Derivados simetricos de triazina.
PL375395A1 (en)	2005-11-28	4-trifluoromethylpyrazolyl substituted pyridines and pyrimidines
ATE370120T1 (de)	2007-09-15	Substituierte 2-pyridin-cyclohexan-1,4- diaminderivate
IS7881A (is)	2005-06-02	CHK-, PDK- og AKT-hindrandi pýrimidín, framleiðsla þeirra og notkun sem lyfjaefni
ATE424202T1 (de)	2009-03-15	Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung
DE50207849D1 (de)	2006-09-28	Substituierte 2-oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre verwendung
DK1397351T3 (da)	2010-01-18	Pyrimidin-, triazin- og pyrazinderivater som glutamatreceptorer
PT102750B (pt)	2004-02-27	Geladeira portatil aperfeicoada
DK1480983T3 (da)	2006-03-27	Heteroarylsubstituerede 2-pyridinyl- og 2-pyrimidinyl- 6,7,8,9-tetrahydropyrimido[1,2a]pyrimidin-4-onderivater
SE0301654D0 (sv)	2003-06-05	Novel compounds
NO20042980L (no)	2004-07-14	3,4-dihydro-1H-isokinolin-2-yl-derivater
NL1019525A1 (nl)	2002-05-22	Het telefonische tijdschakelmechanisme dannobel.
BR8101674Y1 (pt)	2009-08-11	disposição construtiva em tapume.
ES1049974Y (es)	2002-06-01	Mochila perfeccionada.
ES1048344Y (es)	2001-12-01	Mochila perfeccionada.
HK1053645A (en)	2003-10-31	Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
ES1051628Y (es)	2003-01-16	Cuadro decorativo multipieza.